Patents
Patents for C08B 37 - Preparation of polysaccharides not provided for in groups; Derivatives thereof (24,467)
03/2003
03/12/2003EP1291362A1 A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
03/12/2003EP1290184A1 Lactobacillus reuteri glucosyltransferase
03/12/2003EP1290035A1 Fluorescein isothiocyanate (fitc) sinistrin, its production and use
03/12/2003EP1289515A1 Pharmaceutical composition containing at least a polymer associated or conjugated with at least a phenylalkylcarboxylic acid salt, conjugate polymers and uses thereof
03/12/2003EP1289508A2 Method for the prevention of apoptosis
03/12/2003EP1169387B1 Three-dimensional structures containing hyaluronic acid derivatives obtained by the supercritical antisolvent technique
03/12/2003EP0686160A4 Solution and solid-phase formation of glycosidic linkages
03/12/2003CN1402737A 6-mercapto-cyclodextrin derivs.: resersal agent for drug-induced neuromuscular block
03/12/2003CN1401665A Method and material for preparing biomedical material for construction of artificial blood vessel
03/12/2003CN1401664A Method for preparing high relative molecular mass chitin and chitosan, and comprehensive utilization
03/12/2003CN1401663A Method for production of quick dispersion and dissolution mannogalactan gum
03/12/2003CN1401653A Scrophularia oligose, production method and use thereof
03/12/2003CN1102933C Method for recovering cyclodextrin
03/11/2003US6531295 Isolated nucleic acid encoding polypeptide of given amino acid sequence which serves as a glycosaminoglycan attachment site for heparan sulfate chain
03/11/2003US6531178 β-glucan process, additive and food product
03/06/2003WO2003018640A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003WO2003018032A1 Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
03/06/2003WO2003017921A2 A method to improve complexation efficacy and produce high-energy cyclodextrin-complexes
03/06/2003WO2002074200B1 Formulations containing propofol and a sulfoalkyl ether cyclodextrin
03/06/2003WO2002063961B1 Composition and methods for modulation of vascular structure and/or function
03/06/2003US20030045708 Galactomannan compositions and methods for making and using same
03/06/2003US20030045692 Chitin particle for use in solid supports
03/06/2003US20030044942 Functional sugar polymers from inexpensive sugar sources and apparatus for preparing same
03/06/2003US20030044513 Polymerization of mono and disaccharides with monocarboxylic acids and lactones
03/06/2003US20030044479 Process for the production of pure guar meal
03/06/2003CA2458852A1 Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate
03/06/2003CA2457846A1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/05/2003EP1287827A1 Immunopotentiator
03/05/2003EP1287039A1 Amphiphilic macrocyclic derivatives and their analogues
03/05/2003CN1400869A Inulin products with improved nutritional properties
03/05/2003CN1400199A Method for continuously extracting active component from eucommia leaf
03/04/2003US6528643 Lipase-catalyzed alcoholysis; cheap starting material; efficiency
03/04/2003US6528642 Alkenylated cyclodextrin compounds and polymers made tthereof ; made by reacting an alkenyl halide with cyclodextrin; use as support for separation of enantiomers, other isomers, and hydrophobic organic molecules, or as catalyst support
03/04/2003US6528497 Anticoagulant and antithrombotic like heparin; hexadeca saccharides of three distinct sequences: a sulphated penta saccharide sequence DEFGH, a non-sulphated heptasaccharide sequence Z(MN)3 and a sulphated tetrasaccharide sequence VWXY.
03/04/2003US6527887 Polymeric cyclodextrin nitrate esters
02/2003
02/27/2003WO2002068383A3 Thiol-modified hyaluronan
02/27/2003WO2002036799A3 Extracellular polysaccharide from gluconacetobactor spp
02/27/2003WO2002008441A8 Process for producing non-cellulosic callose fiber by plant protoplast and callose fiber
02/27/2003US20030040487 Polymer complexes of glucuronoglucanes
02/27/2003US20030037894 Modified polysaccharide having the following structure: Polysac-Z3R1 where Polysac=a polysacchride, monosaccharide or sugar residue, Z3=a bridging radical, serves to attach R1 group to the polysacchride radical, R1=organofunctional group
02/26/2003EP1285021A1 Material based on biodegradable polymers and method for preparing same
02/26/2003EP1285005A1 Hydrocolloid powder composition exhibiting improved dispersibility in an aqueous medium and method for preparing same
02/26/2003EP1115774B1 Process for the production of polysaccharide beads
02/26/2003EP0691806B1 Method of somatic hybridization of algal species
02/26/2003CN1398902A Extraction process of Fuscoporia obliqua polysaccharide
02/26/2003CN1398901A Prepn and use of curcuma oligosaccharide sulfate derivative
02/26/2003CN1398898A Extraction and separation process of ash tree flower sporophore polyglycopeptide
02/26/2003CN1102154C Acylated gamma-cyclodextrin mixer, its prep. and use
02/26/2003CN1102153C Prep. of water-soluble chitosan
02/26/2003CN1102152C Process for preparing water-soluble chitosan
02/26/2003CN1102151C Method for extracting and separating filiform blue-green alga water-soluble polyose and amylovorin
02/25/2003US6524595 Dermopharmaceuticals.
02/25/2003CA2072291C Compositions for polar solvent fire fighting containing perfluoroalkyl terminated co-oligomer concentrates and polysaccharides
02/23/2003CA2399844A1 Preparation of glucosamine hydrochloride
02/20/2003WO2003014165A1 EXTRACTION OF β-GLUCAN FROM CEREALS
02/20/2003WO2002064556A3 Complex carbohydrate arrays and methods for the manufacture and uses thereof
02/20/2003WO2001093850B1 Methods and compositions using sulodexide for the treatment of diabetic nephropathy
02/20/2003US20030036176 Directed genetic engineering of xanthomonas campestris
02/19/2003EP1283888A2 Fructosyltransferases (inulosucrase and levansucrase) from lactobacillus reuteri
02/19/2003CN1398267A Cyclodextrin ethers
02/19/2003CN1397567A Spiruline polyose, its extraction process and it medical application in increasing white cells and treating cancer
02/19/2003CN1397566A Atractylodes polyose with antineoplastic and immunoregualting functions and its preparing process and application
02/19/2003CN1397565A Inokopolyose derivative and its preparing and application
02/19/2003CN1397545A Process for extracting 4-hydroxy-isoleucine and by-products including feungreek gum from seed of feungreek
02/18/2003US6521223 Reacting anionic polymers with divinyl sulfone, neutralizing, then precipitating solids, then hydrating to form water insoluble biocompatible mucopolysaccharides having storage stability used as antiscarring wound healing agents
02/18/2003CA2112237C Cosmetic compositions containing oligosaccharides
02/13/2003WO2003011912A1 Chitosan preparation
02/13/2003WO2003011307A1 Use of oversulfated polysaccharides as inhibitors of hiv
02/13/2003WO2002102856B1 Method of manufacturing of husk from lepidium sativum seeds
02/13/2003US20030032622 Process for bulk autoclaving
02/13/2003US20030032620 Efficient incorporation in vitro of thymidine, glucosamine and leucine in fibroblast macromolecules of the human cutis. Local application of this compound stimulates fibroblast metabolism.
02/13/2003US20030031684 Growing a culture of a deep rough mutant bacterial strain in a medium, maintaining in stationary phase for > 5hr, harvesting the cells and extracting lipopolysaccharide
02/13/2003US20030029799 Carbohydrate purification using ultrafiltration, reverse osmosis and nanofiltration
02/13/2003US20030029588 Process for the selective modification of carbohydrates by peroxidase catalyzed oxidation
02/13/2003CA2455777A1 Chitosan preparation
02/13/2003CA2454945A1 Use of oversulfated polysaccharides as inhibitors of hiv
02/12/2003EP1283218A1 Compound comprising crosslinked polyrotaxane
02/12/2003EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody
02/12/2003EP1282684A2 Chondroitin synthase gene and methods of making and using same
02/12/2003CN1396930A Devivatives of partially desulphated glycosaminoglycans endowed with antiangiogenic activity and devoid of anticoagulating effect
02/12/2003CN1396185A Hemicellulase and its application in preparing chitoligose
02/12/2003CN1101407C Guarseed flour and preparation method thereof
02/12/2003CN1101406C Method for preparing polysaccharide with fungal cell wall structure
02/12/2003CN1101405C Process for producing hyaluronic acid gel, hyaluronic acid made by the method and medical material containing same
02/12/2003CN1101228C Treatment of conditions and disease
02/12/2003CN1101224C Injection for giving up addiction
02/11/2003US6518249 Oligosaccharide derivatives and process for producing the same
02/11/2003US6517933 Block polymerization of such as chitosan and diglycidyl terminated polyethyleneglycol; combining comfort of natural materials with robustness and designability of synthetics; clothing, home furnishings
02/11/2003US6517678 Modified polysaccharides containing amphiphillic hydrocarbon moieties
02/11/2003CA2257623C Substitutes for modified starch in paper manufacture
02/11/2003CA2257622C Substitutes for modified starch in paper manufacture
02/06/2003WO2003010206A1 Polymers and their synthesis
02/06/2003WO2003010178A1 Functionalised maltosyl fluoride as glycosyl donor in the chemo-enzymatic preparation of oligo- or polysaccharides
02/06/2003WO2002002645A8 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME
02/06/2003US20030027883 Biopolymers obtained by solid state irradiation in an unsaturated gaseous atmosphere
02/06/2003US20030026828 Coupling of modified cyclodextrins to fibers
02/06/2003US20030024662 Cationic cellulosic fibre containing 1-30 cationic groups and 0.1-20 aldehyde groups per 100 anhydroglucose units; aldehyde groups may be reacted with with a nitrogen containing reagent such as betaine hydrazide hydrochloride.
02/06/2003CA2455401A1 Functionalised maltosyl fluoride as glycosyl donor in the chemo-enzymatic preparation of oligo- or polysaccharides
02/05/2003EP1281722A1 Hyaluronic acid gel, process for producing the same, and medical material containing the same
02/05/2003EP1280829A1 Process for preparing chitosan particles